Vertex Pharmaceuticals | VRTX - Trade Creditors



Vertex Pharmaceuticals reported $3.71B in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
AbbVie 2.94B 2.66B Dec/2024
Acadia Pharmaceuticals USD 20.1M 2M Jun/2025
Agios Pharmaceuticals USD 17.53M 3.81M Jun/2025
Alnylam Pharmaceuticals USD 102.39M 4.99M Jun/2025
Amgen USD 18.03B 15.63B Jun/2025
Arrowhead Research USD 33.05M 23.07M Jun/2025
Biogen USD 408.4M 16.9M Jun/2025
BioMarin Pharmaceutical 684.25M 390.5M Jun/2025
Bristol-Myers Squibb USD 5.43B 1.42B Jun/2025
Gilead Sciences USD 582M 155M Jun/2025
Incyte USD 1.41B 1.21B Jun/2025
Insmed USD 78.35M 16.95M Jun/2025
Ionis Pharmaceuticals USD 22.8M 5.34M Jun/2025
J&J USD 9.54B 766M Mar/2025
Merck USD 4.04B 261M Jun/2025
Moderna USD 175M 51M Jun/2025
Neurocrine Biosciences 104.6M 5.4M Jun/2025
Novartis USD 4.51B 245M Jun/2025
Pfizer USD 5.17B 74M Jun/2025
PTC Therapeutics USD 206.31M 191.16M Jun/2025
Regeneron Pharmaceuticals USD 723.9M 18.4M Jun/2025
Roche Holding 4.35B 828M Dec/2024
Sanofi 7.08B 14.54B Jun/2025
Sarepta Therapeutics USD 136.7M 19.4M Jun/2025
Ultragenyx Pharmaceutical USD 34.24M 13.21M Jun/2025
United Therapeutics 432M 426M Jun/2025
Vertex Pharmaceuticals USD 3.71B 3.27B Jun/2025